GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 96 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $158,000 | +36.2% | 11,120 | -53.6% | 0.03% | +7.7% |
| Q4 2018 | $116,000 | -31.8% | 23,947 | +35.9% | 0.03% | -42.2% |
| Q3 2017 | $170,000 | +6.9% | 17,621 | +34.0% | 0.04% | +12.5% |
| Q2 2017 | $159,000 | +12.0% | 13,147 | +18.4% | 0.04% | 0.0% |
| Q1 2017 | $142,000 | -21.5% | 11,100 | -68.5% | 0.04% | -42.9% |
| Q1 2016 | $181,000 | -37.6% | 35,260 | -5.6% | 0.07% | -11.4% |
| Q4 2015 | $290,000 | -24.3% | 37,357 | -23.2% | 0.08% | -58.0% |
| Q3 2015 | $383,000 | -49.5% | 48,629 | -41.7% | 0.19% | +11.2% |
| Q2 2015 | $759,000 | – | 83,431 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|